-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Mineralys Therapeutics, Inc. annual/quarterly Depreciation, Depletion and Amortization history and growth rate from 2023 to 2024.
- Mineralys Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $8K.
- Mineralys Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2024 was $43K.
Depreciation, Depletion and Amortization, Annual (USD)